| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 7623 | 2021 |
| Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells H Yuzugullu, K Benhaj, N Ozturk, S Senturk, E Celik, A Toylu, N Tasdemir, ... Molecular cancer 8 (1), 1-20, 2009 | 236 | 2009 |
| Transforming growth factor‐beta induces senescence in hepatocellular carcinoma cells and inhibits tumor growth S Senturk, M Mumcuoglu, O Gursoy‐Yuzugullu, B Cingoz, KC Akcali, ... Hepatology 52 (3), 966-974, 2010 | 201 | 2010 |
| Senescence and immortality in hepatocellular carcinoma M Ozturk, A Arslan-Ergul, S Bagislar, S Senturk, H Yuzugullu Cancer letters 286 (1), 103-113, 2009 | 97 | 2009 |
| Rapid and tunable method to temporally control gene editing based on conditional Cas9 stabilization S Senturk, NH Shirole, DG Nowak, V Corbo, D Pal, A Vaughan, ... Nature Communications 8 (1), 1-10, 2017 | 86 | 2017 |
| Reprogramming of replicative senescence in hepatocellular carcinoma-derived cells N Ozturk, E Erdal, M Mumcuoglu, KC Akcali, O Yalcin, S Senturk, ... Proceedings of the National Academy of Sciences 103 (7), 2178-2183, 2006 | 78 | 2006 |
| p53Ψ is a transcriptionally inactive p53 isoform able to reprogram cells toward a metastatic-like state S Senturk, Z Yao, M Camiolo, B Stiles, T Rathod, AM Walsh, ... Proceedings of the National Academy of Sciences 111 (32), E3287-E3296, 2014 | 64 | 2014 |
| Inhibition of Akt signaling in hepatoma cells induces apoptotic cell death independent of Akt activation status F Buontempo, T Ersahin, S Missiroli, S Senturk, D Etro, M Ozturk, ... Investigational new drugs 29 (6), 1303-1313, 2011 | 57 | 2011 |
| MYC drives Pten/Trp53-deficient proliferation and metastasis due to IL6 secretion and AKT suppression via PHLPP2 DG Nowak, H Cho, T Herzka, K Watrud, DV DeMarco, VMY Wang, ... Cancer discovery 5 (6), 636-651, 2015 | 51 | 2015 |
| TP53 exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic functions NH Shirole, D Pal, ER Kastenhuber, S Senturk, J Boroda, P Pisterzi, ... Elife 5, e17929, 2016 | 36 | 2016 |
| Imetelstat (a telomerase antagonist) exerts off‑target effects on the cytoskeleton I Mender, S Senturk, N Ozgunes, K Akcali, D Kletsas, S Gryaznov, A Can, ... International Journal of Oncology 42 (5), 1709-1715, 2013 | 32 | 2013 |
| Next-generation liver medicine using organoid models S Akbari, N Arslan, S Senturk, E Erdal Frontiers in cell and developmental biology 7, 345, 2019 | 25 | 2019 |
| The ability to generate senescent progeny as a mechanism underlying breast cancer cell heterogeneity M Mumcuoglu, S Bagislar, H Yuzugullu, H Alotaibi, S Senturk, ... PloS one 5 (6), e11288, 2010 | 23 | 2010 |
| Thioredoxin interacting protein promotes invasion in hepatocellular carcinoma A Gunes, E Bagirsakci, E Iscan, G Cakan-Akdogan, U Aykutlu, S Senturk, ... Oncotarget 9 (96), 36849, 2018 | 9 | 2018 |
| Genomics and functional genomics of malignant pleural mesothelioma E Cakiroglu, S Senturk International Journal of Molecular Sciences 21 (17), 6342, 2020 | 6 | 2020 |
| The Jekyll and Hyde of Cellular Senescence in Cancer D Demirci, B Dayanc, FA Mazi, S Senturk Cells 10 (2), 208, 2021 | 4 | 2021 |
| A rapid and tunable method to temporally control Cas9 expression enables the identification of essential genes and the interrogation of functional gene interactions in vitro … S Senturk, NH Shirole, DD Nowak, V Corbo, A Vaughan, DA Tuveson, ... bioRxiv, 023366, 2015 | 3 | 2015 |
| Retinoic acid signaling and bladder cancer: Epigenetic deregulation, therapy and beyond G Ozgun, S Senturk, S Erkek‐Ozhan International Journal of Cancer 148 (10), 2364-2374, 2021 | 1 | 2021 |
| Special Focus Issue Part II: Recruitment of solid lipid nanoparticles for the delivery of CRISPR/Cas9: primary evaluation of anticancer gene editing H Akbaba, G Erel-Akbaba, S Senturk Nanomedicine 16 (12), 963-978, 2021 | 1 | 2021 |
| Correction: TP53 exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic functions NH Shirole, D Pal, ER Kastenhuber, S Senturk, J Boroda, P Pisterzi, ... Elife 6, e25532, 2017 | 1 | 2017 |
Mehmet OzturkIzmir Biomedicine and Genome Center, Dokuz Eylul University, Izmir, TurkeyVerifierad e-postadress på deu.edu.tr
